‘I Am Going To Be Applying To McDonald's': Dubai Doctor Fears Losing Job To AI
Last Updated:
A pulmonologist in Dubai expressed concern that AI might replace him after using it to analyse X-rays.
A surprising claim came from a Dubai-based doctor who joked that artificial intelligence (AI) might replace him. He humorously added that if he loses his job, he might have to apply at McDonald's.
Dr. Mohammad Fawzi Katranji, a veteran pulmonologist with 18 years of experience specialising in critical care and sleep medicine, shared his reaction on Instagram. He tested an AI tool by having it analyse patient X-rays to see if the technology could match his medical conclusions.
'So, I am about to lose my job. This is scary because I developed a skill over 20 years, which lets me look at an X-ray and point to pneumonia," he explained, pointing to an X-ray of lungs. He then turned the screen to show a different scan with two highlighted regions, the exact areas he had used to diagnose the patient's pneumonia.
'Now, here comes AI, and it points it out in a second. So, you don't need professional eyes to look at these X-rays; you just used artificial intelligence. So, I am going to be applying to McDonald's soon, and I hope they have some openings," he remarked.
The doctor, however, praised the technology after it detected an anomaly in a scan that he hadn't noticed. After prescribing medication for the condition, the patient began to improve.
'It's not easy realising your skills need to evolve. AI is coming. I have to admit: AI helped find the diagnosis here," he wrote in the caption of the clip.
Watch The Video:
Shared on May 20, the video has already garnered over 10,000 views. Other medical professionals and AI enthusiasts, surprised by the pulmonologist's response to AI, shared their reactions.
A user suggested, 'AI will enable you to help more people and take more time for each patient of yours. It's a gain and an opportunity and not a threat for great doctors like you!"
Another user pointed out that while AI can detect abnormalities, it takes a skilled physician to interpret their significance. 'This video is embarrassing. Any competent radiologist would have dismissed the findings even after AI's 'help," the individual said.
AI in healthcare is evolving from a supplementary aid to a potentially transformative force. Diagnostic tools like Lunit INSIGHT CXR now match or even surpass the accuracy of human physicians.
First Published:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
3 hours ago
- Hindustan Times
Microsoft unveils new Xbox handheld video game devices, partners with ASUS
Microsoft on Sunday revealed its first Xbox-branded handheld video game devices, presenting them as a way to play its extensive library of titles anywhere. The two models of "ROG Xbox Ally", created in partnership with Taiwan-based ASUS will be available in the market by the holiday season at the end of the year, said Xbox president Sarah Bond during an online event. "The Xbox Ally is an Xbox you can hold in your hands, bringing together the power of Xbox and the freedom of Windows," Bond added. She also said that on this version of Xbox, users will be able to pick any game across their entire library, including all of the Windows PC game stores from Xbox and to Steam, GOG (Good Old Games platform) and Ubisoft Connect. The ROG Xbox Ally model is described as the essential handheld at a great value for everyone, from casual players to avid gamers. Meanwhile, the ROG Xbox Ally X model is the ultimate high-performance handheld gaming device, built for the most demanding players. The Xbox Ally is powered by the AMD Ryzen™ Z2 A Processor, with 16 GB of RAM and 512GB of SSD storage. Meanwhile, Xbox Ally X features AMD Ryzen™ AI Z2 Extreme processor, with 24GB of high-speed RAM and 1TB in storage. Additionally, Xbox also made exciting offers to players who purchase the new model and are new to Game Pass. It said that these players will be get started with no extra cost and will also access hundreds of games such as Balatro, Gears Tactics, Vampire Survivors and more, straight from their device.
Economic Times
3 hours ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
&w=3840&q=100)
Business Standard
4 hours ago
- Business Standard
We're the largest gig worker employer in the country: Rapido cofounders
We're currently in over 35 cities with taxis and aim to be present in every district headquarters, says Rapido Surajeet Das Gupta Bengaluru Listen to This Article Bengaluru-based startup Rapido, which joined the unicorn club last year, has disrupted the mobility business by shifting from a commission to a subscription model for drivers across vehicle categories. It recently added taxis, prompting rivals Ola and Uber to follow suit. Rapido cofounders Pavan Guntupalli and Aravind Sanka, in an interview with Surajeet Das Gupta in Bengaluru, discuss their push to become a mass-market mobility player, ongoing goods and services tax (GST) and regulatory challenges, and the government's electric vehicle (EV) drive. Edited excerpts:
